Son et al. who studied COVID‐19 patients with varying acute‐phase severities, reported persistence of certain autoantibodies for up to 1 year after infection, among them anti‐U1‐snRNP, anti‐SSB/La and anti‐PM‐Scl [33]. Here, PRB1 is linked to infection.